Hyperfine, Inc. (NASDAQ:HYPR) Stock Has Average Price Target of $2.02

Hyperfine, Inc. (NASDAQ:HYPR) has been given an average recommendation of “Moderate Buy” by the six research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $2.02.

A number of equities research analysts have issued reports on HYPR shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, October 15th. Lucid Cap Mkts assumed coverage on Hyperfine in a research report on Tuesday, October 27th. They set a “strong-buy” rating on the stock. BTIG Research reaffirmed a “buy” rating and set a $2.00 price objective on shares of Hyperfine in a research report on Tuesday, September 22nd. Wall Street Zen cut Hyperfine from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Loop Capital set a $2.00 target price on Hyperfine in a report on Tuesday.

Institutional Investors Weigh In On Hyperfine

A number of hedge funds have recently bought and sold shares of HYPR. Renaissance Technologies LLC increased its stake in shares of Hyperfine by 100.2% during the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after buying an additional 365,490 shares during the period. Bank of New York Mellon Corp acquired a new stake in Hyperfine in the second quarter valued at approximately $419,000. Walleye Capital LLC raised its holdings in Hyperfine by 3.4% in the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after acquiring an additional 7,330 shares in the last quarter. Finally, PFS Partners LLC lifted its stake in Hyperfine by 150.0% in the third quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock worth $40,000 after acquiring an additional 30,000 shares during the last quarter. Institutional investors and hedge funds own 15.03% of the company’s stock.

Hyperfine Stock Performance

NASDAQ HYPR opened at $0.72 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 6.15 and a quick ratio of 5.45. The company has a market cap of $76.36 million, a P/E ratio of -1.89 and a beta of 1.45. The stock has a 50-day moving average of $0.81 and a two-hundred day moving average of $1.12. Hyperfine has a 1-year low of $0.70 and a 1-year high of $1.94.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting the consensus estimate of ($0.09). The business had revenue of $3.90 million during the quarter, compared to analyst estimates of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. As a group, analysts anticipate that Hyperfine will post -0.34 EPS for the current year.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.